Verona Pharma plc (VRNA)
NASDAQ: VRNA · Real-Time Price · USD
38.85
+0.76 (2.00%)
At close: Nov 20, 2024, 4:00 PM
39.45
+0.60 (1.54%)
Pre-market: Nov 21, 2024, 7:23 AM EST
Verona Pharma Market Cap
Verona Pharma has a market cap or net worth of $3.18 billion as of November 21, 2024. Its market cap has increased by 152.48% in one year.
Market Cap
3.18B
Enterprise Value
2.97B
1-Year Change
152.48%
Ranking
Category
Stock Price
$38.85
Market Cap Chart
Since April 27, 2017, Verona Pharma's market cap has increased from $167.09M to $3.18B, an increase of 1,802.69%. That is a compound annual growth rate of 47.55%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denali Therapeutics | 3.50B |
| Envista Holdings | 3.49B |
| Acadia Healthcare Company | 3.45B |
| Neogen | 3.27B |
| BrightSpring Health Services | 3.25B |
| MoonLake Immunotherapeutics | 3.11B |
| Agios Pharmaceuticals | 3.10B |
| PTC Therapeutics | 3.04B |